1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Single Dose, Dose Escalation Clinical Trial on the Safety, Tolerability and Efficacy of Lyophilized Powder for Inhalation of Recombinant Human Keratinocyte Growth Factor-2 (Rh-KGF-2) in The Treatment of Patients With Acute Respiratory Distress SyndromeHemic and Lymphatic Diseases, Lung Injury, Neoplasms by Histologic Type, acute lung injury, follicular lymphoma, immune system disorder, immunoproliferative disorder, lung disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, respiratory system disorderRecruitingEarly phase 12026-06-11NCT07558538